Stock Events

Stock Events

China SXT Pharmaceuticals 

€0
47
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2RY1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
111
YI
Mkt Cap51.31M
111, Inc. operates a leading direct-to-patient digital healthcare platform in China, offering similar pharmaceutical products and services, thus competing in the same market space.
Zai Lab Limited
ZLAB
Mkt Cap2.42B
Zai Lab Limited is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines in China, directly competing in the pharmaceutical innovation and distribution sector.
HUTCHMED (China) Limited
HCM
Mkt Cap2.29B
Hutchison China MediTech Limited engages in the research, development, and commercialization of therapies in oncology and autoimmune diseases, competing for market share in China's pharmaceutical sector.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. specializes in the research, development, manufacturing, and commercialization of vaccines, competing in the healthcare and pharmaceutical market in China.
Can-Fite Biopharma
CANF
Mkt Cap7.11M
Can-Fite BioPharma Ltd. is an advanced clinical stage drug development company with a platform aimed at addressing cancer, liver, and inflammatory diseases, competing in the pharmaceutical market.
Novartis
NVS
Mkt Cap279.67B
Novartis AG, a multinational pharmaceutical company, offers a broad range of healthcare products that compete in the Chinese market, including innovative medicines and generics.
Pfizer
PFE
Mkt Cap149.77B
Pfizer Inc., a global biopharmaceutical company, competes in China through its wide range of healthcare products, including vaccines, oncology, and internal medicine.

About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Show more...
CEO
Mr. Feng Zhou
Employees
75
Country
Virgin Islands (British)

Listings

STU
DE
2RY1.STU
MU
DE
2RY1.MU
XNAS
US
SXTC
BOATS
BOATS
SXTC.BOATS

0 Comments

Share your thoughts

FAQ

What is China SXT Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange China SXT Pharmaceuticals stocks are traded under the ticker 2RY1.STU.
How many employees does China SXT Pharmaceuticals have?▼
As of May 07, 2026, the company has 75 employees.
In which sector is China SXT Pharmaceuticals located?▼
China SXT Pharmaceuticals operates in the Essentials sector.
When did China SXT Pharmaceuticals complete a stock split?▼
The last stock split for China SXT Pharmaceuticals was on February 03, 2026 with a ratio of 1:50.
Where is China SXT Pharmaceuticals headquartered?▼
China SXT Pharmaceuticals is headquartered in Taizhou, Virgin Islands (British).